MapLight Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher A. Kroeger, with a market cap of $712.4M.
Upcoming earnings announcement for MapLight Therapeutics, Inc.
Past 1 earnings report for MapLight Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Dec 4, 2025 | Q3 2025 | -$37.18Est: -$1.36 | -2633.8% | - | — |
We use cookies for analytics. See our Privacy and Cookie Policy.